help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Manchon, C.
Right arrow Articles by Vale, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Manchon, C.
Right arrow Articles by Vale, W.

Endocrinology, Vol 125, 1666-1672, Copyright © 1989 by Endocrine Society


ARTICLES

Activin-A, inhibin and transforming growth factor-beta modulate growth of two gonadal cell lines

C Gonzalez-Manchon and W Vale
Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, California 92037.

The proliferative and differentiating effects of the gonadal hormones inhibin and activin-A were examined on cell lines derived from the ovary and testis. Activin-A was found to inhibit the growth of CHO-K1 (Chinese hamster ovary) cells in culture, with an IC50 of 3 ng/ml. The maximal response (50% inhibition) required 3 days of incubation in the presence of 40 ng/ml activin-A, and the inhibitory effect was accompanied by morphological changes. Inhibin (10 ng/ml) partially blocked the inhibition of growth by activin. Transforming growth factor- beta (TGF beta), which is structurally related to activin and inhibin, was a very potent inhibitor of the proliferation of CHO-K1 cells, with an IC50 of 0.2 ng/ml and a maximal effect (70% inhibition) at 2 ng/ml. The combination of high concentrations of both TGF beta and activin-A did not result in a greater inhibitory effect than that observed with TGF beta alone, suggesting an overlapping step in the mechanism of action for both factors. In contrast to the results with CHO-K1 cells, differential effects of activin-A and TGF beta were observed in R2C (rat Leydig cell testicular tumor) cells. Activin-A had only a slight effect on proliferation over a 4-day incubation, but inhibited progesterone accumulation ina concentration-dependent fashion within 12 h. TGF beta, on the other hand, was a potent inhibitor of both growth and steroidogenesis in R2C cells. These studies suggest that activin-A and inhibin may regulate proliferation as well as functions of gonadal cells.


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. L. Mellor, E. M. A. Ball, A. E. O'Connor, J.-F. Ethier, M. Cranfield, J. F. Schmitt, D. J. Phillips, N. P. Groome, and G. P. Risbridger
Activin {beta}C-Subunit Heterodimers Provide a New Mechanism of Regulating Activin Levels in the Prostate
Endocrinology, October 1, 2003; 144(10): 4410 - 4419.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Funaba, T. Ikeda, K. Ogawa, M. Murakami, and M. Abe
Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration
J. Leukoc. Biol., June 1, 2003; 73(6): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. J. Duleba, T. Pehlivan, R. Carbone, and R. Z. Spaczynski
Activin Stimulates Proliferation of Rat Ovarian Thecal-Interstitial Cells
Biol Reprod, September 1, 2001; 65(3): 704 - 709.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Zhou, H. Sun, D. C. Danila, S. R. Johnson, D. P. Sigai, X. Zhang, and A. Klibanski
Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling
Mol. Endocrinol., December 1, 2000; 14(12): 2066 - 2075.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. C. Cipriano, L. Chen, T. R. Kumar, and M. M. Matzuk
Follistatin Is a Modulator of Gonadal Tumor Progression and the Activin-Induced Wasting Syndrome in Inhibin-Deficient Mice
Endocrinology, July 1, 2000; 141(7): 2319 - 2327.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
X. Ni, S. Luo, T. Minegishi, and C. Peng
Activin A in JEG-3 Cells: Potential Role as an Autocrine Regulator of Steroidogenesis in Humans
Biol Reprod, May 1, 2000; 62(5): 1224 - 1230.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Expression of Prolactin-Releasing Peptide and Its Receptor Messenger Ribonucleic Acid in Normal Human Pituitary and Pituitary Adenomas
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4652 - 4655.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Mizunuma, X. Liu, K. Andoh, Y. Abe, J. Kobayashi, K. Yamada, H. Yokota, Y. Ibuki, and Y. Hasegawa
Activin from Secondary Follicles Causes Small Preantral Follicles to Remain Dormant at the Resting Stage
Endocrinology, January 1, 1999; 140(1): 37 - 42.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Ishisaki, K. Yamato, A. Nakao, K. Nonaka, M. Ohguchi, P. ten Dijke, and T. Nishihara
Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells
J. Biol. Chem., September 18, 1998; 273(38): 24293 - 24296.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Lejeune, F. Chuzel, P. Sanchez, P. Durand, J. P. Mather, and J. M. Saez
Stimulating Effect of Both Human Recombinant Inhibin A and Activin A on Immature Porcine Leydig Cell Functions in Vitro
Endocrinology, November 1, 1997; 138(11): 4783 - 4791.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Gnessi, A. Fabbri, and G. Spera
Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment
Endocr. Rev., August 1, 1997; 18(4): 541 - 609.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Yamato, T. Koseki, M. Ohguchi, M. Kizaki, Y. Ikeda, and T. Nishihara
Activin A Induction of Cell-Cycle Arrest Involves Modulation of Cyclin D2 and p21CIP1/WAF1 in Plasmacytic Cells
Mol. Endocrinol., July 1, 1997; 11(8): 1044 - 1052.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. W. M. Martens, J. P. de Winter, M. A. Timmerman, A. McLuskey, R. H. N. van Schaik, A. P. N. Themmen, and F. H. de Jong
Inhibin Interferes with Activin Signaling at the Level of the Activin Receptor Complex in Chinese Hamster Ovary Cells
Endocrinology, July 1, 1997; 138(7): 2928 - 2936.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Moustakas, T. Takumi, H. Y. Lin, and H. F. Lodish
GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A
J. Biol. Chem., January 13, 1995; 270(2): 765 - 769.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. Albano, N Groome, and J. Smith
Activins are expressed in preimplantation mouse embryos and in ES and EC cells and are regulated on their differentiation
Development, January 2, 1993; 117(2): 711 - 723.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society